Sofosbuvir ( @ mg once daily ) and LDV ( @ mg once daily ) plus ribavirin ( RBV ) were given for @ weeks to treatment-nave ( TN ) patients ( n = @ ) and those who did not respond to previous therapy ( prior null responders , n = @ ) .